Medtronic (MDT) Other financing activities (2014 - 2026)

Medtronic has disclosed Other financing activities across 13 years of filings, most recently posting -$5.0 million for Q1 2026.

• Other financing activities for Q1 2026 came in at -$5.0 million, down 103.12% year-over-year; the trailing twelve-month figure through Jan 2026 was -$220.0 million (down 260.58% YoY), and the FY2025 annual result was -$184.0 million, down 6033.33% from the prior year.
• Other financing activities came in at -$5.0 million for Q1 2026 at Medtronic, roughly flat from -$5.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $273.0 million in Q3 2022 to a low of -$719.0 million in Q1 2023.
• The 5-year median for Other financing activities is -$5.0 million (2025), against an average of -$19.2 million.
• Across the five-year window, Other financing activities jumped 6925.0% in 2022 and sank 11883.33% in 2023, its largest moves.
• Medtronic's Other financing activities stood at $170.0 million in 2022, then fell by 5.29% to $161.0 million in 2023, then slumped by 130.43% to -$49.0 million in 2024, then jumped by 89.8% to -$5.0 million in 2025, then changed by 0.0% to -$5.0 million in 2026.
• The last three Other financing activities figures came in at -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and $70.0 million (Q3 2025), per Business Quant data.